Winrevair (sotatercept-csrk) is used to help increase exercise capacity, improve WHO functional class, and reduce the risk of disease progression in pulmonary arterial hypertension (PAH). It is administered via subcutaneous injection, typically every three weeks after the initial treatment.

Common side effects include
- Show Full Answer

Winrevair (sotatercept-csrk) is used to help increase exercise capacity, improve WHO functional class, and reduce the risk of disease progression in pulmonary arterial hypertension (PAH). It is administered via subcutaneous injection, typically every three weeks after the initial treatment.

Common side effects include:
- Headaches
- Nosebleeds
- Rash
- Small dilated blood vessels near the skin’s surface
- Diarrhea
- Dizziness
- Skin redness and discoloration

Rare but serious side effects include:
- Severe thrombocytopenia (low platelet count)
- Erythrocytosis (high red blood cell count)

It's important to have your blood hemoglobin and platelet counts checked regularly. If you have any concerns or unusual symptoms, please consult your healthcare provider.

 This AI-generated response comes from myPHteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Winrevair (Sotatercept-csrk) for Pulmonary Hypertension | myPHteam

Ventavis (Iloprost) for Pulmonary Hypertension | myPHteam